John Sepulveda

John Sepulveda practices at Northern Infusion in Arecibo, Puerto Rico.

John Sepulveda's NPI, 1619013109, was assigned on January 30, 2007. John Sepulveda graduated from San Juan Bautista School of Medicine in 1985. John Sepulveda holds Puerto Rico license 8228.

John Sepulveda's primary practice is Northern Infusion, at 162 Calle Jose Rodriguez Iriz, Arecibo, PR 00612. The practice phone is (787) 815-1563. The NPI Registry lists John Sepulveda's practice address as 210 Manuel Domenech, San Juan, PR 00918.

John Sepulveda's primary practice is Northern Infusion in Arecibo, Puerto Rico. John Sepulveda is also affiliated with Hospital Metropolitano Dr. Susoni. The medical group on file is Northern Infusion. Dmand AI also links John Sepulveda to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where John Sepulveda practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is John Sepulveda's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. John Sepulveda is licensed in Puerto Rico.

CMS data shows 66 Medicare services from John Sepulveda across 2 procedure codes in 2024, for 28 Medicare patients. Medicare paid $3,881 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 28 Medicare patients who saw John Sepulveda in 2024. 75% of them have diabetes, and 75% have high blood pressure. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts John Sepulveda's median patient age at 80, with 50% women.

In 2024, John Sepulveda wrote 826 Medicare Part D claims for 217 patients. 78% of them were for generic drugs. CMS names the drug for 574 of them, across 25 drugs with 11 or more claims each, at $556,742 in total drug cost. In 2023, CMS named 466 claims across 17 drugs.

John Sepulveda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 350 procedures of removal of tissue by John Sepulveda, more than 95% of the clinicians it reports for that procedure.

CMS Open Payments shows 12 general payments to John Sepulveda from 7 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 69% of the total. Merck Sharp & Dohme Corporation paid the most, $1,658.

John Sepulveda graduated from San Juan Bautista School of Medicine in 1985.